Bayer Shares Drop 6.5% as Supreme Court Appears Split Over Roundup Appeal

Key Facts

Bayer AG shares tumbled by 6.5% following reports that the U.S. Supreme Court appeared split during deliberations over the company's appeal to limit Roundup weedkiller lawsuits. The German conglomerate is seeking a definitive judicial ruling to curb its legal liability and manage the thousands of ongoing cases alleging the product causes cancer. Bayer's legal strategy hinges on the argument that federal labeling laws should preempt state-level failure-to-warn claims. The apparent lack of consensus among the justices has injected fresh uncertainty into the market, weighing heavily on the company's valuation. This development marks a critical phase in Bayer's long-standing effort to resolve a litigation crisis that has strained its finances and investor confidence for years.

Version History